Metal toxicity is a pervasive global health problem due to the increasing bioavailability of non-essential metals
Introduction
Metalloproteins play crucial biochemical roles based on their interactions with essential metal ions, particularly Ca 2+ , Zn 2+ , and Mg 2+ . More than a third of all known proteins have evolved over time to utilize these essential metals for a variety of purposes, including structural stabilization, protein/enzyme activation, regulation of cellular activity, signal transduction, and synaptic activity. Metalloproteins can also interact with non-essential metals, which may result in metal dyshomeostasis and toxicity to the organism.
Lead (Pb 2+ ), as a product of human industry, has long been known as a toxic metal, and despite regulatory efforts, it remains a persistent source of environmental toxicity. Exposure occurs primarily through consumption or inhalation, and due to its close relationship with Ca 2+ -dependent biochemical processes, Pb 2+ can remain a chronic long-term problem due to bone adsorption [1] . Immediately following exposure, approximately 20% of Pb 2+ is redistributed through the bloodstream to various tissues, presumably through transportation by proteins such as divalent metal transporter-1 (DMT1), where Pb 2+ occupies the metal binding sites [2, 3] , or calbindin, another Ca 2+ -binding protein (CaBP) that also binds Pb 2+ with nearly equivalent affinity (~5 µM) to that of the Ca 2+ -sensor protein calmodulin (CaM) [4, 5] .
In humans, Pb 2+ is responsible for a wide array of systemic problems related to blood, kidneys, male and female fertility, and neurological functions [6] [7] [8] [9] , as well as potential cancers [10] . It is now known that Pb 2+ ions can traverse both the blood-brain barrier (BBB) and the placenta in pregnant women [11, 12] . Children are generally most susceptible to Pb 2+ neurotoxicity, which can impair cognitive functions and produce irreversible IQ loss, even at very low exposure levels [13] [14] [15] [16] [17] , leading to long-term behavioral disorders [18] [19] [20] . Additionally, in what seems an odd paradox, exposure to trace concentrations of Pb 2+ may be more deleterious than higher concentrations in the GABAergic system during embryonic development [21] , where ɣ-aminobutyric acid (GABA) is extremely important for neuronal migration, neurite growth, and synaptogenesis [22] .
The primary mechanism historically associated with metal toxicity was presumed to involve ionic displacement, where non-essential metal ions would replace essential metal ions in protein binding sites, thereby altering the structure and/or function of the protein. However, there is a growing body of research suggesting that the ionic displacement model does not adequately address the complex interactions between metals and proteins, and the mechanisms which may lead to cellular toxicity and interference with important physiological and neurological processes. Several recent review papers have highlighted research suggesting multiple mechanisms associated with metal toxicity, particularly with respect to disruption of synaptic activity and neural pathways by substitution of Pb 2+ for Ca 2+ and Zn 2+ in proteins [1, [23] [24] [25] . [26] by influx and efflux through membrane permeable Ca 2+ channels, regulated by various control mechanisms and events, including membrane depolarization, external agonists, and depletion of internal stores in the sarcoplasmic reticulum (SR) and endoplasmic reticulum (ER). Within the cell, movement of Ca 2+ from internal ER and SR Ca 2+ stores is mediated by the sarco/endoplasmicreticulum-Ca 2+ -ATPase (SERCA), IP 3 receptors (IP 3 R) [27, 28] and ryanodine receptors (RyR) [29] .
Neurons, like other cells, contain numerous proteins that interact either directly or indirectly with Ca 2+ as part of a broader Ca 2+ -dependent signaling system [30] . Changes in the free Ca 2+ concentration regulates signaling in neural pathways along the CNS by triggering neurotransmitter release in synapses. Within the neural signaling pathway, which includes a vast network of more than 1000 neurons in the human brain [31] , communication between neural cells across the synaptic cleft is initiated by a change in the action potential on the surface of the presynaptic neuron that regulates the opening of voltage-gated calcium channels (VGCC's) (Figure 1 ). Once the channel is open, the influx of Ca 2+ interacts with CaBPs associated with various aspects of neurotransmission, cognitive function, memory, and synaptic activity [24] . These proteins include synaptotagmin, ɣ-aminobutyric acid (GABA) receptors, Neuronal calcium sensor protein 1 (NCS-1), and CaM ( Figure 2) . Additionally, proteins like CaM, once activated by Ca 2+ , will interact with other downstream proteins involved in neurotransmission, including CaM-dependent kinase II (CaMKII), metabotropic glutamate receptors (mGluR's), N-methyl-D-aspartate receptors (NMDARs), and calcineurin ( Figure 2 ).
Zn

2+ -signaling in Cells
In addition to Ca 2+ , it is becoming increasingly evident that Zn 2+ also plays a prominent role in neural activity. Research suggests that as much as 10% of the eukaryotic genome may encode zinc proteins [32] . Until recently, Zn 2+ was assumed to perform primarily structural and catalytic roles as a metal co-factor [33] , but studies have now reported that Zn 2+ acts as a neurotransmitter, and performs regulatory activities as a secondary intracellular messenger in signal transduction [34, 35] . At the synapses of glutamatergic neurons, Zn 2+ interacts with both Zn 2+ transporters and receptors (e.g., NMDARs), and effectively functions as a neuroprotector for these signaling pathways [36] [37] [38] [39] . Moreover, Zn 2+ plays an important role in the neural activity of synaptic vesicles [40] and control of dendritic cells; functions as an intracellular signaling molecule, similar to Ca 2+ [41] ; and can regulate neurotransmission and synaptic plasticity [42, 43] when released from synaptic vesicles. Similarly, several related studies have reported that decreased Zn 2+ availability may impair neural development by inhibiting activation of extracellular signal-regulated kinases (ERK1/2) [44] , and may inhibit LTP and cognition [45] .
Within the cell, the concentration of free Zn 2+ is tightly-regulated in the pM range [46] by the actions of Zn 2+ transporters, metallothioneins (MTs), and metal responsive proteins, like metal regulatory transcription factor 1 (MTF1) [47] , and most Zn 2+ is bound to zinc proteins with picomolar affinities (Figure 2 ) [48] , thus limiting the availability of free Zn 2+ . It has been suggested that extracellular signaling regulates intracellular Zn 2+ concentration by altering expression of Zn 2+ transporters [47] . These Zn 2+ transporters, broadly classified into two major families, SLC30 and SLC39 [49, 50] , permit movement both in and out of cells, and appear to participate in transportation of excess Zn 2+ which can be sequestered in the ER and Golgi apparatus [51, 52] . Qin et al further demonstrated a relationship between ER Ca 2+ stores and Zn 2+ dynamics, indicating a concerted interplay between ions in the two signaling pathways where an increase in cytosolic Ca 2+ released from the ER is associated with a concomitant decrease in Zn 2+ from the ER, and homeostasis for each ion appears dependent on the other [52] . In addition to this reported relationship between cytosolic ion concentrations, various studies have identified proteins within the Ca 2+ -signaling network that appear to be regulated by both Zn 2+ and Ca 2+ , including calnexin and calreticulin [53] , CaM, protein kinase C (PKC), and G-protein coupled receptors (GPCRs) [47] . In the Ca 2+ -binding protein CaM, auxiliary Zn 2+ and Mg 2+ binding sites have been reported that may allosterically modulate protein activity [54] , and at least two Zn 2+ -binding sites have also been identified in the GABA receptor [55] , which interacts with the Ca 2+ /CaM complex. Similarly, Zn 2+ may function as an agonist with GPCRs; as a cofactor with Ca 2+ to cooperatively regulate PKC activity [56, 57] ; and as a cofactor with the Ca 2+ /CaM complex that regulates CaMKII [58] . Results of these studies support an activity model in neurons where at least some of the Ca 2+ and Zn 2+ signaling activities are integrated, although current limitations in our knowledge of Zn 2+ -signaling and related proteins would make it difficult to estimate the extent to which these two pathways may intersect.
Metal ion coordination in proteins
The divalent Ca 2+ and Zn 2+ ions exhibit very different properties. The Ca 2+ ion is significantly larger than Zn 2+ , and Ca 2+ is classified as a weakly-polarizable hard Lewis acid, whereas Zn 2+ is borderline ( Figure 03A ), indicating that it shares some features of both hard and soft Lewis acids, and these differences have important implications for their interactions with proteins. Ca 2+ -binding sites predominantly utilize oxygen ligands (e.g., side-chain oxygen from Asp and Glu, main-chain carbonyl oxygen, and water) with a higher coordination number (6-8 ligands), whereas Zn 2+ -binding sites preferentially utilize sulfur (Cys) or nitrogen (His) over oxygen, with fewer coordinating ligands (4-6), depending on the ions role with respect to the protein [59] . Binding geometries can vary, based on coordination number, but a pentagonal bipyramid is frequently observed for canonical Ca 2+ EF-hand binding sites ( Figure 3B ), while tetrahedral or octahedral ( Figure 3C ) is common for Zn 2+ sites in proteins.
Both metal ions interact with numerous metal-specific proteins and enzymes, but because of the differences in metal properties, there is little competition between the two ions for their respective binding sites. [60] . Consistent with these observations, evidence summarized recently in our lab and others increasingly indicates that Pb 2+ neurotoxicity is related to interference with synaptic activity [61, 62] , which is likely associated with disruption of Zn 2+ and Ca 2+ -dependent functions by Pb 2+ [23, 24] .
Metal Toxicity
Metal dyshomeostasis, in a broad sense, encompasses abnormalities in the relative concentrations of physiologically important metal ions, including the introduction of non-essential metals. Disruption of metal homeostasis appears to be a significant factor in a number of neurodegenerative diseases [1] . Anomalies in trace essential metals, such as copper, may play important roles in Parkinson Disease (PD) [63] and Alzheimer's disease (AD) [64] , while exposure to non-essential metals has been implicated in both multiple sclerosis (MS) [65] and amyotrophic lateral sclersosis (ALS) [66] . Protein aggregation, observed in a number of neurodegenerative disorders, may be induced by various conditions, including protein misfolding due to interactions with metals [67, 68] , and the accumulation of zinc, copper, and iron has been reported in conjunction with amyloid formation in AD [69] . Additionally, certain metals may produce oxidative damage in proteins, which represents another mechanism associated with neurodegenerative pathologies [70] . This last mechanism will not be addressed in this review. 
Pb
2+ Toxicity
To understand the mechanisms associated with Pb 2+ toxicity, it is necessary to understand how the properties of the Pb 2+ ions influence their interactions with various proteins. As a borderline Lewis Acid ( Figure 3A) , Pb 2+ can display properties of either hard or soft acids, which would allow it to replace a variety of different metal ions in proteins. Indeed, studies have demonstrated that Pb 2+ can displace Mg 2+ in pyrimidine 5'-nucleotidase type 1 [71] , Fe 2+ in divalent cation transporter-1 [2] , Zn 2+ in 5-aminolevulinic acid dehydratase (ALAD) [72, 73] , and Ca 2+ in a variety of Ca 2+ -binding proteins (CaBPs) [74] [75] [76] [77] [78] including PKC [79, 80] , synaptotagmin [81] , and CaM [78, 82] ; all proteins involved in neural pathways that represent targets for Pb 2+ -induced neurotoxicity. A comprehensive statistical analysis of Pb 2+ -bound structures in the Protein DataBank (PDB), revealed that Pb 2+ is remarkably adept at occupying the binding sites of physiologically relevant metal ions, despite differences in coordination numbers, coordination geometries, and ligand type [60] . Additionally, Pb 2+ was observed to bind in regions of proteins outside of previously identified primary metal binding sites, including potential auxiliary binding sites for Mg 2+ and Zn 2+ in CaM that may allosterically inhibit function of the protein [54] . Thus, the picture of Pb 2+ that emerged from this study was that of a highly promiscuous ion capable of not only replacing essential metal ions in their respective binding sites, which was consistent with an ionic mimicry model for metal toxicity [83] , but also capable of binding opportunistically to other regions of the protein outside of the known binding sites, which could destabilize the protein and/or alter its conformation and subsequent function.
To address these questions, a follow-up study was conducted that compared structural differences and binding affinities for Pb 2+ and Ca 2+ bound to CaM [84] . [85, 86] , and with a related study by Dowd et al which reported that occupancy of Pb 2+ in Ca 2+ -binding sites may activate a protein, mimicking the presence of Ca 2+ , but may also result in a more compact conformation of the protein [87] . Results of these studies also suggest potential mechanisms through which protein aggregation could occur as a result of toxic metals interacting with metalloproteins, but in a broader sense, it suggests that the ability of toxic metals to interact with proteins outside of know binding sites expands the range of protein interactions that may occur, resulting in protein misfunction.
Most recently, our hypotheses and conclusions from these previous studies were applied to address potential avenues of Pb 2+ neurotoxicity through the various Ca 2+ -dependent proteins involved in neurotransmission [24] . However, given that Pb 2+ can also occupy Zn 2+ -binding sites, and the potential intersections that occur between Ca 2+ -and Zn 2+ -signaling pathways, the discussion of Pb 2+ neurotoxicity and its effects on synaptic activity should also address Zn 2+ -dependent proteins as potential targets. At present, we are just beginning to piece together the myriad components within a vast calcium-signaling network, and our current state of knowledge pertaining to zinc signaling is even more limited. Hence, the focus of this article will highlight and expand aspects of our recent review [24] , focusing on proteins involved in synaptic activity that represent known or potential targets for Pb 2+ (Figure 2 ) [88] , and Ca 2+ channels are the likely points of entry for Pb 2+ into the cell. Additionally, interaction of Pb 2+ with presynaptic VGCC's may impair GABAergic synaptic transmission by inhibiting GABA release [89] , which is believed to be related to learning and memory.
NMDA receptor
NMDA receptors (Figure 2 ) are ionotropic glutamate receptors in the central nervous system (CNS), that are important for learning, memory LTP, synaptic plasticity, and development of neurons [90, 91] . The NMDA receptor is a tetramer in neural cells comprised of two NR1 (GluN1) and two NR2 (GluN2) subunits that form a Ca 2+ channel, and once activated by Glu and Gly, plays important roles in presynaptic activity by releasing trans-synaptic signaling molecules, including brain-derived neurotrophic factor (BDNF) [92] [93] [94] [95] , and increasing the intracellular Ca 2+ concentration. NMDA receptors can bind both Zn 2+ and Mg 2+ , which allosterically inhibits opening of the channel, thus restricting Ca 2+ influx ( Figure 2) . Depolarization of the cell can prevent binding of Zn 2+ and Mg 2+ to the receptor, but not Pb 2+ [96] [97] [98] , and research indicates that Pb 2+ , which can occupy both Zn 2+ and Mg 2+ binding sites, functions as an antagonist [99, 100] to disrupt developing synapses by reducing production of synaptic proteins Syn and Syb [101] . Additionally, the influx of Ca 2+ through the NMDAR Ca 2+ channel can activate CaM, and the Ca 2+ /CaM complex can inactivate the NMDAR receptor by displacing α-actinin from the C0 domain of the receptor NR1 subunit of the receptor [102] . Hence [103] . CaM functions specific to neurotransmission and synaptic activity include: gene expression, neurotransmission, and modifications to synaptic plasticity [104, 105] ; activation of short transient receptor potential channel 5 (TrpC5) proteins, which form Ca 2+ -channels and regulate neuron growth cone formation [106] ; and mediation of post-synaptic long-term plasticity through activation of CaMKIIα and calcineurin [107, 108] . CaM may also be involved in auxiliary regulation of neurotransmitter release not regulated by synaptotagmin [109] , and regulation of presynaptic release through interaction with calmodulin-dependent kinase-IIα (CaMKIIα) and CaMKIIβ ( Figure 2 ) [110] .
Finally, CaM modulates Ca 2+ -signaling by altering intracellular Ca 2+ concentrations through interactions with pre-and post-synaptic Ca 2+ channels [111, 112] , and through inhibition of Ca 2+ release from intracellular stores when it binds inositol 1,4,5-trisphosphate receptor type 1 (IP 3 R1) [113, 114] .
Various studies have reported that Pb 2+ interacts with CaM in a concentration-dependent manner, producing a biphasic response characterized by activation of CaM at lower Pb 2+ concentrations, followed by deactivation of the protein with increasing Pb 2+ concentration [85, 86] . Additionally, Pb 2+ at low concentrations can release norepinephrine (NE) in bovine neuroendocrine chromaffin cells [115] . These results suggest that, at lower concentrations, Pb 2+ mimics Ca 2+ by ionic replacement in structured Ca 2+ -binding sites, which would inappropriately activate the protein. Conversely, at higher concentrations, Pb 2+ appears to interact with CaM through a different mechanism involving opportunistic binding outside of the known Ca 2+ -binding sites, or in auxiliary binding sites for Zn 2+ and Mg 2+ , resulting in allosteric inhibition of protein activity [84] . Thus, CaM likely represents an important participant in Pb 2+ neurotoxicity across a range of Pb 2+ concentrations, and due to its ubiquitous presence across a multitude of functions regulated by the Ca 2+ -signaling network.
Synaptotagmin
Synaptotagmin I is a Ca 2+ -binding protein responsible for neurotransmitter release, mediated by changes in Ca 2+ concentration (Figure 1 ) [116] [117] [118] . This protein consists of a transmembrane domain and an intravesicular N-terminal cytosolic domain that contains two C2 Ca 2+ -binding domains (C2A and C2B). Synaptotagmin I interacts with both anionic phospholipids [119] and the protein syntaxin [120] [121] [122] through its C2A domain [118] . Research has demonstrated that synaptotagmin binds Pb 2+ with higher affinity than Ca 2+ , and at nanomolar concentrations, Pb 2+ mimics the effects of Ca 2+ [123] . For example, both Ca 2+ and Pb 2+ were observed to protect synaptotagmin I from proteolysis; however, the Pb 2+ -bound synaptotagmin did not subsequently interact with syntaxin, indicating that while the protein structure was stabilized by Pb 2+ , protein activity and the associated Ca 2+ -mediated neurotransmitter release were inhibited.
Additionally, the introduction of low concentrations of Pb 2+ (~10 µM) causes dimerization of synaptotagmin II, and formation of a multimer at 1.1 mM Pb 2+ , which is only observed with Ca 2+ at a much higher concentrations (5 mM) [124] . Thus, Pb 2+ may inactivate synaptotagmin through protein aggregation.
ɣ-aminobutyric acid (GABA)B receptors
The ɣ-aminobutyric acid (GABA)B receptors, are members of the family C of G-protein-coupled receptors (GPCRs) [125] , which can protect neurons from pathological stresses [126] .
Glutamatergic and GABAergic neurotransmitters are associated with processes related to emotions, learning and memory [127, 128] , and in the CNS of adults, GABA is the primary inhibitory neurotransmitter. The activity of cGPCRs is mediated either directly by Ca 2+ -binding, or indirectly through interactions with CaBPs (e.g., CaM). Hence, Pb 2+ can interfere with the Ca 2+ -dependent activity of these receptors directly or indirectly, and studies have demonstrated that exposure to low levels of Pb 2+ can reduce Ca 2+ -dependent glutamate and γ-aminobutyric acid release in the hippocampus [89, 129, 130] indicative of presynaptic neuron dysfunction.
Additionally, during early CNS development, GABA is critical for neuronal migration, neurite growth, axonal growth, and synaptogenesis [22] . Exposure to Pb 2+ appears to inhibit both excitatory postsynaptic currents (EPSCs) and inhibitory postsynaptic currents (IPSCs), resulting in reduced neurotransmission in the glutamatergic and GABAergic systems associated with hippocampal neurons [131] . Moreover, expression levels of presynaptic proteins synaptophysin (Syn) and synaptobrevin (Syb) were both reduced, accompanied by reduction in the release of vesicular neurotransmitters associated with glutamatergic and GABAergic synapses, in the presence of Pb 2+ [132] . Further studies have reported that adverse effects of Pb 2+ on the GABAergic system during CNS development is dependent on the level of exposure, and the stage of development [21] , where low concentrations of Pb 2+ (50 ppb) reduced expression of GABA genes at 48 hours post-fertilization (hpf), but subsequently increased gene expression at 60 hpf, at the same concentration. The significance of this is not clear, but given that lower concentrations of Pb 2+ can mimic the presence of Ca 2+ in the protein Ca 2+ -binding site, it is possible that these effects indicate false activation of the protein, and this dyshomeostasis may be related to differences in neurotoxicity observed between adults and children. Conversely, these results may indicate interaction of Pb 2+ with a Zn 2+ binding site [55] .
Calcineurin
Calcineurin (CaN) is a serine/threonine protein phosphatase associated with activation of T cells, and which appears to also play an important role in cognitive function and long-term memory [108, 133] . The function of heterodimeric CaN is regulated by binding of the Ca 2+ /CaM complex in the CaM binding domain (Figure 2) [133] , and thus, there are multiple points within this signaling pathway where Pb 2+ can disrupt normal activities through replacement of Ca 2+ or Zn 2+ or a mechanism of opportunistic binding.
mGLuR1
Metabotropic glutamate receptor 1 (mGluR1) is activated by L-glutamate (L-Glu), the major CNS excitatory neurotransmitter, which generates a signal cascade resulting in increased intracellular calcium concentration ([Ca 2+ ] i ) [134] [135] [136] , and activation of PKC [137] . PKC is a family of proteins that mediate multiple cellular processes, including CNS development. Several isoforms of PKC are activated by Ca 2+ , and can be activated by Pb 2+ at subnanomolar concentrations [79, 80, 138, 139] , which has been associated with loss of cognitive skills [140] .
Research also suggests that mGluR1 is modulated by extracellular Ca 2+ [141] , and interacts with CaM, and binding of CaM may be inhibited by PKC phosphorylation of mGluR5 [142] and mGLuR7 [143] . Moreover, chronic Pb 2+ exposure appears to reduce mRNA expression of both PKC and CaM in the hippocampus [144] . Thus, there appears to be strong relationship between Ca 2+ -signaling and activities that relate mGluR1, PKC, and CaM, and Pb 2+ -neurotoxicity [24] .
NCS-1
Neuronal calcium sensor protein 1 (NCS-1) is a Ca 2+ -sensing protein that contains three canonical EF-Hand Ca 2+ binding motifs and a non-functional pseudo-EF-Hand motif in the N-domain. The N-domain also contain a myristoylation site that may enable membrane association of the protein (Figure 2 ) [145] . NCS-1 is similar to CaM in function and sensitivity to small increases in Ca 2+ concentration, although they share only 20% sequence identity [30] .
As summarized in our previous review [24] , Ca 2+ -activated NCS-1 interacts with downstream proteins associated with neural activity, including calcineurin (Figure 2 ), Ca 2+ -dependent activator protein for secretion (CAPS), PI4KIIIβ [146, 147] , ARFI [30, 147] and dopamine receptor D2R [148] . NCS-1 participates in the regulation of synaptic transmission through its interaction with Ca 2+ -channel α1-subunit [149] , and it can also inhibit neurite outgrowth by interactions with short transient receptor potential channel 5 (TRPC5) Ca 2+ channels [150, 151] .
In our previous review, we further proposed the hypothesis that NCS-1 represents a likely target for Pb 2+ neurotoxicity due to its EF-Hand Ca 2+ binding sites, and similarity to CaM, which is known to bind Pb 2+ , although no link between Pb 2+ and NCS-1 has yet been established in the scientific literature. In the event of such a link, Pb 2+ could either activate or inhibit NCS-1, thus affecting its downstream protein interactions, including those involved with neurotransmission directly, and those involved with other cellular activities that may indirectly affect neurotransmission. Two potential downstream interactions worth noting are ARF1 and CAPS1. The first example, ARF1 (ADP-ribosylation factor 1), is a GTPase that participates in the regulation of vesicular trafficking in cells [30, 152] , and performs several important functions at the Golgi complex related to vesicle coat assembly and trafficking [153] . Since ARF1 interacts with NCS-1, it represents an indirect target for Pb 2+ neurotoxicity via Ca 2+ dyshomeostasis.
The second example includes the CAPS isoforms CAPS1 and CAPS2, found in neuroendocrine cells and the brain. CAPS1 is an intracellular protein involved in large dense-core vesicle (LDCV) exocytosis and neurotransmitter release, whereas CAPS2 is also expressed in the lung, liver, and testis [154] . During human embryotic development, low expression of the CAPS1 isoform is observed prior to birth, but expression then increases until postnatal day 21. However, CAPS2 expression is constant beginning at embryonic day 10 and continues for the first 60 days postnatal. Additionally, the BBB is considerably more permeable during fetal development, and as such, is more susceptible to the neurotoxic effects of Pb 2+ [155] . Hence the effects of Pb 2+ on neural development, synaptic plasticity, and synaptic activity, may vary based on the concentrations of proteins available at a given time during human development, as well as Pb 2+ concentrations, which could explain some of the observed differences in neurotoxic effects between children and adults exposed to Pb 2+ .
MTF1 and metallothionein
At present, metal regulatory transcription factor 1 (MTF1) is the only known eukaryotic Zn 2+ -sensor [34] , which makes it comparable in that respect to CaM. MTF1 is a zinc finger protein with six cysteine clusters capable of binding Zn 2+ ,
and subsequently initiating expression of metallothionein, a protein that resides in the Golgi apparatus and mediates cellular Zn 2+ concentrations [156] . Metallothionein is the primary protein in cells, including neurons, responsible for removal of Pb 2+ and other potentially toxic metals [157] , and at least two distinct Pb-MT complexes, Pb7-MT2(I) and Pb7-MT2(II), can form under different pH conditions [158] . Hence 
Conclusions
Research presented in this review suggests that metal neurotoxicity may involve overlapping mechanisms. For example, as previously noted, NCS-1 inhibits neurite outgrowth by interactions with short transient receptor potential channel 5 (TRPC5) Ca 2+ channels [150, 151] , while conversely, TRPC5 is activated by the Ca 2+ /CaM complex. Additionally, TRPC5 may be directly activated by low concentrations of Pb 2+ [159] , which is not related to CaM activity. Thus. At least three distinct paths have been identified through which Pb 2+ may affect TRCP5, which would further complicate elucidation of a molecular mechanism of toxicity. 
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